STIM Hisse Senedi Fiyat Grafiği
Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
04
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Neuronetics, Inc. - Common Stock Hakkında
Wikipedia'dan şirket genel bakışı
05 · wikidata
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration (FDA) approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device (FDA approval K061053)."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık
Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
STIM
5Y ort.
Akran Ortalaması
Sonuç
Brüt Kar Marjı (TTM)
49.1%5Y ort. ≈69.7%
≈69.7%
51.1%
Aynı seviyede
Faaliyet Kâr Marjı (TTM)
-14.7%5Y ort. ≈-42.7%
≈-42.7%
0.77%
Ortalamanın altında
FAVÖK Marjı (TTM)
-12.7%5Y ort. ≈-40.3%
≈-40.3%
0.77%
Ortalamanın altında
Net Kâr Marjı (TTM)
-19.6%5Y ort. ≈-48.0%
≈-48.0%
-2.9%
Zayıf
ROA (TTM)
-22.9%5Y ort. ≈-29.0%
≈-29.0%
-18.1%
Zayıf
ROE (TTM)
-135.3%5Y ort. ≈-104.5%
≈-104.5%
-13.7%
Zayıf
Finansal Sağlık
Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
STIM
5Y ort.
Akran Ortalaması
Sonuç
Borç / Öz Sermaye (MRQ)
3.45Y ort. ≈1.5
≈1.5
0.4
Yüksek borç
Cari Oran (MRQ)
1.95Y ort. ≈3.8
≈3.8
2.3
Ortalamanın altında
Quick Ratio (Cari Oran)
1.55Y ort. ≈3.1
≈3.1
1.5
Aynı seviyede
Uzun Vadeli Borç / Özkaynak (MRQ)
3.45Y ort. ≈1.5
≈1.5
·
·
Büyüme
Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
STIM
5Y ort.
Akran Ortalaması
Sonuç
Revenue YoY (Gelir Yıllık Bazda)
99.2%5Y ort. ≈28.8%
≈28.8%
·
·
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
31.8%5Y ort. ≈18.5%
≈18.5%
·
·
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
24.8%
·
·
·
Hisse Başı Metrikler
Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü
Metrik
5 Yıllık trend
STIM
5Y ort.
Akran Ortalaması
Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))
$-0.595Y ort. ≈$-1.12
≈$-1.12
·
·
Revenue / Share (Hisse Başına Gelir)
$2.265Y ort. ≈$2.34
≈$2.34
·
·
Cash Flow / Share (Hisse Başına Nakit Akışı)
$-0.315Y ort. ≈$-0.93
≈$-0.93
·
·
Cash / Share (Hisse Başına Nakit)
$0.415Y ort. ≈$1.79
≈$1.79
·
·
Sermaye Verimliliği
Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
STIM
5Y ort.
Akran Ortalaması
Sonuç
Asset Turnover (Aktif Devir Hızı)
1.15Y ort. ≈0.7
≈0.7
1.1
Aynı seviyede
Inventory Turnover (Stok Devir Hızı)
17.95Y ort. ≈5.6
≈5.6
3.5
En üst düzey
Receivables Turnover (Alacak Devir Hızı)
7.55Y ort. ≈5.9
≈5.9
6.0
En üst düzey
Revenue / Employee (Çalışan Başına Gelir)
≈$226.7K
·
·
·
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi
EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
14
Ort. Sürpriz-11.0%
Sonraki RaporKas 02, 2026
Dönem
Rapor
EPS Gerçek
EPS Tahmin
Sürpriz
30 Haziran 2026
Ağu 3, 2026
$-0.04
$-0.12
68.0%
31 Mart 2026
May 12, 2026
$-0.15
$-0.18
15.2%
31 Aralık 2025
$-0.10
$-0.11
8.1%
30 Eylül 2025
$-0.13
$-0.13
-0.62%
30 Haziran 2025
$-0.15
$-0.08
-91.8%
31 Mart 2025
$-0.21
$-0.13
-64.7%
Tüm Temeller
Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
15
Gelir Tablosu16
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
$149M
$75M
$71M
$65M
$55M
$49M
$63M
$53M
$40M
Cost of Revenue
$77M
$21M
$20M
$15M
$12M
$12M
$15M
$12M
$10M
Gross Profit
$72M
$54M
$52M
$50M
$44M
$38M
$47M
$40M
$31M
R&D Expense
$7M
$13M
$10M
$9M
$8M
$9M
$14M
$8M
$8M
SG&A Expense
$50M
$30M
$25M
$26M
$26M
$18M
$17M
$14M
$9M
Operating Expenses
$104M
$89M
$82M
$85M
$71M
$60M
$74M
$60M
$44M
Operating Income
$-31M
$-35M
$-31M
$-35M
$-28M
$-22M
$-27M
$-20M
$-14M
Interest Expense
·
$7M
$5M
$4M
$4M
$5M
$4M
$4M
$3M
Other Non-op
$716.0K
$3M
$6M
$2M
$390.0K
$302.0K
$2M
$-575.0K
$357.0K
Pretax Income
·
·
·
·
·
·
$-29M
$-24M
$-16M
Net Income
$-39M
$-44M
$-30M
$-37M
$-31M
$-27M
$-29M
$-24M
$-16M
EPS (Basic)
$-0.59
$-1.38
$-1.05
$-1.38
$-1.22
$-1.46
$-1.58
·
·
EPS (Diluted)
$-0.59
$-1.38
$-1.05
$-1.38
$-1.22
$-1.46
$-1.58
·
·
Shares (Basic)
65,951,000
31,734,000
28,658,000
26,900,000
25,479,000
18,835,000
18,380,000
·
·
Shares (Diluted)
65,951,000
31,734,000
28,658,000
26,900,000
25,479,000
18,835,000
18,380,000
·
·
EBITDA
$-28M
$-32M
$-29M
$-33M
$-27M
$-21M
$-26M
$-19M
·
Bilanço24
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
Cash & Equivalents
$28M
$18M
$60M
$70M
$94M
$49M
$76M
$105M
$29M
Receivables
$16M
$23M
$16M
$14M
$8M
$7M
$7M
$6M
$4M
Inventory
$4M
$4M
$8M
$9M
$7M
$4M
$3M
$2M
$2M
Prepaid Expense
$3M
$7M
$5M
$2M
$3M
$2M
$2M
$2M
$1M
Current Assets
$62M
$58M
$94M
$99M
$115M
$65M
$88M
$114M
$37M
PP&E (Net)
$4M
$6M
$2M
$2M
$1M
$730.0K
$1M
$1M
$1M
PP&E (Gross)
$9M
$9M
$5M
$5M
$4M
$3M
$3M
$3M
$3M
Accum. Depreciation
$4M
$3M
$3M
$3M
$3M
$2M
$2M
$2M
$2M
Goodwill
$24M
$19M
·
·
·
·
·
·
·
Intangibles
$18M
$20M
·
·
·
·
·
·
·
Other Non-current Assets
$2M
$2M
$4M
$4M
$2M
$2M
$1M
$1M
$574.0K
Total Assets
$142M
$141M
$116M
$117M
$141M
$79M
$100M
$117M
$39M
Accounts Payable
$11M
$11M
$5M
$2M
$4M
$4M
$5M
$4M
$3M
Accrued Liabilities
$12M
$13M
$13M
$15M
$8M
$7M
$9M
$8M
$8M
Current Liabilities
$31M
$31M
$20M
$33M
$16M
$14M
$28M
$14M
$12M
Capital Leases
$19M
$23M
$2M
$3M
$4M
$3M
$3M
·
·
Total Liabilities
$115M
$109M
$82M
$60M
$56M
$53M
$52M
$46M
$44M
Long-term Debt
$66M
$55M
$59M
$36M
$35M
$35M
$31M
$30M
$30M
Total Debt
$66M
$55M
$59M
$36M
$35M
$35M
$31M
$30M
·
Common Stock
$690.0K
$557.0K
$291.0K
$273.0K
$264.0K
$191.0K
$186.0K
$177.0K
$2.0K
Retained Earnings
$-459M
$-420M
$-376M
$-346M
$-309M
$-278M
$-250M
$-221M
$-197M
Stockholders' Equity
$22M
$28M
$34M
$57M
$85M
$25M
$48M
$71M
$-193M
Liabilities + Equity
$142M
$141M
$116M
$117M
$141M
$79M
$100M
$117M
$39M
Shares Outstanding
68,994,000
55,679,000
29,092,000
27,268,000
26,395,000
19,114,000
18,645,000
17,744,000
231,000
Nakit Akışı14
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
D&A
$3M
$2M
$2M
$2M
$1M
$941.0K
$1M
$882.0K
$596.0K
Stock-based Comp
$7M
$6M
$7M
$9M
$8M
$4M
$3M
$2M
$496.0K
Deferred Tax
$0
$0
$0
$0
$0
$0
$0
$0
$0
Amort. of Intangibles
$2M
$100.0K
·
·
·
·
·
·
·
Other Non-cash
$8M
$5M
$-11M
$-4M
$-6M
$-6M
$-6M
$881.0K
·
Operating Cash Flow
$-20M
$-31M
$-32M
$-31M
$-28M
$-28M
$-30M
$-21M
$-11M
CapEx
$801.0K
$1M
$2M
$3M
$2M
$730.0K
$813.0K
$1M
$594.0K
Investing Cash Flow
$-801.0K
$-2M
$-1M
$7M
$-10M
$-730.0K
$-813.0K
$-1M
$-594.0K
Debt Issued
$10M
$57M
$25M
·
·
$41M
·
·
·
Net Debt Issued
$10M
$-3M
$24M
·
·
$2M
·
·
·
Stock Issued
·
·
·
·
$81M
·
·
·
·
Net Stock Activity
·
·
·
·
$81M
·
·
·
·
Financing Cash Flow
$36M
$-7M
$23M
$207.0K
$83M
$2M
$2M
$97M
$24M
Free Cash Flow
$-21M
$-32M
$-34M
$-34M
$-30M
$-29M
$-31M
$-22M
·
Kârlılık7
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
Gross Margin
48.5%
72.3%
72.5%
76.3%
78.9%
·
·
76.4%
·
Operating Margin
-21.1%
-46.2%
-42.8%
-53.8%
-49.8%
·
·
-37.6%
·
Net Margin
-26.2%
-58.4%
-42.3%
-57.0%
-56.4%
·
·
-45.7%
·
Pretax Margin
·
·
·
·
·
·
·
-45.7%
·
EBITDA Margin
-18.8%
-43.4%
-40.0%
-51.3%
-47.9%
·
·
-35.9%
·
ROA
-27.6%
-34.1%
-25.9%
-28.8%
-28.4%
-30.7%
-26.8%
-30.9%
·
ROE
-155.7%
-185.6%
-83.7%
-61.9%
-35.4%
-103.6%
-56.9%
-32.7%
·
Likidite ve Solventlik5
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
Current Ratio
2.0
1.9
4.7
3.0
7.3
4.8
3.2
8.4
·
Quick Ratio
1.5
1.3
3.8
2.5
6.5
4.1
3.0
8.1
·
Debt / Equity
2.9
2.0
1.7
0.6
0.4
1.4
0.7
0.4
·
LT Debt / Equity
2.9
2.0
1.7
0.4
0.4
1.4
0.4
0.4
·
Interest Coverage
·
-4.7
-5.6
-8.3
-6.9
-4.9
-7.3
-5.4
·
Verimlilik3
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
Asset Turnover
1.1
0.6
0.6
0.5
0.5
·
·
0.7
·
Inventory Turnover
17.9
3.4
2.3
2.0
2.3
3.6
5.9
5.1
·
Receivables Turnover
7.5
3.8
4.9
6.1
7.4
·
·
10.7
·
Hisse Başına5
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
Book Value / Share
$0.32
$0.50
$1.18
$2.09
$3.23
$1.33
$2.57
$4.00
·
Revenue / Share
$2.26
$2.36
$2.49
$2.42
$2.17
·
·
·
·
Cash Flow / Share
$-0.31
$-0.98
$-1.12
$-1.14
$-1.10
·
·
·
·
Cash / Share
$0.41
$0.33
$2.05
$2.58
$3.57
$2.56
$4.06
$5.89
·
EPS (TTM)
$-0.59
$-1.38
$-1.05
$-1.38
$-1.22
$-1.46
$-1.58
·
·
Büyüme Oranları3
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue YoY
99.2%
5.0%
9.4%
17.9%
12.3%
·
·
·
·
Revenue CAGR 3Y
31.8%
10.6%
13.2%
·
·
·
·
·
·
Revenue CAGR 5Y
24.8%
·
·
·
·
·
·
·
·
Değerleme (TTM)14
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue TTM
$149M
$75M
$71M
$65M
$55M
$49M
$63M
$53M
·
Net Income TTM
$-39M
$-44M
$-30M
$-37M
$-31M
$-27M
$-29M
$-24M
·
Market Cap
$95M
$90M
$84M
$187M
$118M
$212M
$84M
$343M
·
Enterprise Value
$133M
$126M
$84M
$153M
$59M
$198M
$39M
$269M
·
P/E
-2.3
-1.2
-2.8
-5.0
-3.7
-7.6
-2.8
·
·
P/S
0.6
1.2
1.2
2.9
2.1
4.3
1.3
6.5
·
P/B
4.3
3.2
2.5
3.3
1.4
8.3
1.7
4.8
·
P / Tangible Book
·
·
2.5
3.3
1.4
8.3
·
·
·
P / Cash Flow
-4.7
-2.9
-2.6
-6.1
-4.2
-7.5
-2.7
-16.7
·
P / FCF
-4.5
-2.8
-2.5
-5.5
-3.9
-7.3
-2.7
-15.9
·
EV / EBITDA
-4.8
-3.9
-2.9
-4.6
-2.2
-9.3
-1.5
-14.2
·
EV / FCF
-6.3
-3.9
-2.4
-4.5
-1.9
-6.8
-1.3
-12.5
·
EV / Revenue
0.9
1.7
1.2
2.3
1.1
4.0
0.6
5.1
·
Earnings Yield
-42.8%
-85.7%
-36.2%
-20.1%
-27.4%
-13.1%
-35.2%
·
·
Gelir Tablosu15
Metrik
Eğilim
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Revenue
$42M
$34M
$42M
$37M
$38M
$32M
$22M
$19M
$16M
$17M
$20M
$18M
$18M
$16M
$18M
$16M
Cost of Revenue
$20M
$18M
$20M
$20M
$20M
$16M
$8M
$5M
$4M
$4M
$5M
$6M
$5M
$4M
$4M
$4M
Gross Profit
$21M
$16M
$22M
$17M
$18M
$16M
$15M
$14M
$12M
$13M
$16M
$12M
$13M
$11M
$14M
$13M
R&D Expense
$1M
$1M
$2M
$2M
$2M
$2M
$6M
$2M
$2M
$2M
$2M
$2M
$2M
$3M
$3M
$2M
SG&A Expense
$11M
$13M
$13M
$11M
$12M
$13M
$11M
$7M
$6M
$6M
$6M
$6M
$6M
$7M
$6M
$6M
Operating Expenses
$23M
$25M
$27M
$24M
$26M
$27M
$26M
$22M
$21M
$20M
$20M
$21M
$20M
$21M
$22M
$20M
Operating Income
$-2M
$-9M
$-5M
$-7M
$-8M
$-11M
$-11M
$-8M
$-9M
$-7M
$-4M
$-9M
$-7M
$-10M
$-8M
$-7M
Interest Expense
$2M
$2M
·
$2M
$2M
$2M
·
$2M
$2M
$2M
·
$1M
$1M
$1M
$1M
$1M
Other Non-op
$162.0K
$1M
$155.0K
$126.0K
$188.0K
$247.0K
$545.0K
$539.0K
$653.0K
$812.0K
$893.0K
$664.0K
$4M
$640.0K
$648.0K
$906.0K
Net Income
$-3M
$-11M
$-7M
$-9M
$-10M
$-13M
$-13M
$-13M
$-10M
$-8M
$-5M
$-9M
$-5M
$-11M
$-8M
$-8M
EPS (Basic)
$-0.05
$-0.16
$-0.10
$-0.13
$-0.15
$-0.21
$-0.34
$-0.44
$-0.33
$-0.27
$-0.17
$-0.33
$-0.17
$-0.38
$-0.30
$-0.28
EPS (Diluted)
$-0.05
$-0.16
$-0.10
$-0.13
$-0.15
$-0.21
$-0.34
$-0.44
$-0.33
$-0.27
$-0.17
$-0.33
$-0.17
$-0.38
$-0.30
$-0.28
Shares (Basic)
73,129,000
69,589,000
·
67,309,000
66,180,000
61,465,000
·
30,267,000
30,052,000
29,472,000
·
28,876,000
28,590,000
28,034,000
·
26,965,000
Shares (Diluted)
73,129,000
69,589,000
·
67,309,000
66,180,000
61,465,000
·
30,267,000
30,052,000
29,472,000
·
28,876,000
28,590,000
28,034,000
·
26,965,000
EBITDA
·
$-8M
·
$-7M
$-8M
$-10M
·
$-8M
$-9M
$-6M
·
$-9M
$-7M
$-9M
·
$-7M
Bilanço25
Metrik
Eğilim
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Cash & Equivalents
$19M
$13M
$28M
$28M
$11M
$20M
$18M
$21M
$43M
$48M
$60M
$36M
$46M
$55M
$70M
$74M
Receivables
$16M
$16M
$16M
$19M
$26M
$26M
$23M
$17M
$17M
$18M
·
$15M
$13M
$9M
·
$12M
Inventory
$6M
$5M
$4M
$4M
$5M
$4M
$4M
$5M
$6M
$7M
·
$10M
$9M
$9M
·
$9M
Prepaid Expense
$4M
$4M
$3M
$4M
$4M
$5M
$7M
$5M
$4M
$4M
·
$5M
$5M
$2M
·
$3M
Current Assets
$53M
$47M
$62M
$65M
$56M
$61M
$58M
$53M
$76M
$82M
·
$71M
$78M
$81M
·
$101M
PP&E (Net)
$3M
$4M
$4M
$5M
$5M
$6M
$6M
$2M
$2M
$2M
·
$2M
$2M
$2M
·
$2M
PP&E (Gross)
$7M
$8M
$9M
$9M
$9M
$9M
$9M
$5M
$5M
$5M
·
$6M
$5M
$5M
·
$5M
Accum. Depreciation
$4M
$4M
$4M
$4M
$4M
$4M
$3M
$3M
$3M
$3M
·
$4M
$3M
$3M
·
$3M
Goodwill
$24M
$24M
$24M
$23M
$19M
$19M
$19M
·
·
·
·
·
·
·
·
·
Intangibles
$17M
$18M
$18M
$19M
$19M
$19M
$20M
·
·
·
·
·
·
·
·
·
Other Non-current Assets
$3M
$2M
$2M
$2M
$2M
$2M
$2M
$5M
$5M
$5M
·
$4M
$4M
$3M
·
$4M
Total Assets
$132M
$125M
$142M
$145M
$135M
$142M
$141M
$74M
$97M
$104M
·
$93M
$100M
$104M
·
$119M
Accounts Payable
$12M
$11M
$11M
$12M
$10M
$8M
$11M
$3M
$4M
$3M
·
$3M
$4M
$5M
·
$2M
Accrued Liabilities
$9M
$10M
$12M
$10M
$11M
$9M
$13M
$11M
$9M
$9M
·
$10M
$8M
$7M
·
$11M
Current Liabilities
$28M
$28M
$31M
$29M
$28M
$25M
$31M
$17M
$29M
$14M
·
$15M
$15M
$15M
·
$25M
Capital Leases
$20M
$19M
$19M
$19M
$20M
$22M
$23M
$2M
$2M
$2M
·
$3M
$3M
$3M
·
$3M
Other Non-current Liabilities
$142.0K
$71.0K
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Total Liabilities
$110M
$108M
$115M
$114M
$103M
$102M
$109M
$65M
$77M
$76M
·
$55M
$55M
$55M
·
$56M
Long-term Debt
$62M
$61M
$66M
$66M
$56M
$55M
$55M
$46M
$60M
$59M
·
$37M
$37M
$37M
·
$36M
Total Debt
·
$61M
·
$66M
$56M
$55M
·
$46M
$60M
$59M
·
$37M
$37M
$37M
·
$36M
Common Stock
$762.0K
$696.0K
$690.0K
$685.0K
$661.0K
$658.0K
$557.0K
$303.0K
$301.0K
$300.0K
·
$289.0K
$288.0K
$285.0K
·
$270.0K
Retained Earnings
$-473M
$-470M
$-459M
$-452M
$-443M
$-432M
$-420M
$-407M
$-394M
$-384M
·
$-371M
$-361M
$-356M
·
$-338M
Stockholders' Equity
$18M
$13M
$22M
$27M
$27M
$35M
$28M
$9M
$19M
$28M
·
$38M
$45M
$48M
·
$63M
Liabilities + Equity
$132M
$125M
$142M
$145M
$135M
$142M
$141M
$74M
$97M
$104M
·
$93M
$100M
$104M
·
$119M
Shares Outstanding
76,193,000
69,583,000
68,994,000
68,445,000
66,113,000
65,820,000
55,679,000
30,317,000
30,136,000
29,975,000
·
28,902,000
28,813,000
28,465,000
·
27,060,000
Nakit Akışı13
Metrik
Eğilim
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
D&A
$729.0K
$745.0K
$767.0K
$886.0K
$901.0K
$911.0K
$446.0K
$512.0K
$555.0K
$560.0K
$503.0K
$499.0K
$488.0K
$516.0K
$604.0K
$387.0K
Stock-based Comp
$688.0K
$2M
$2M
$1M
$2M
$1M
$1M
$1M
$2M
$1M
$2M
$2M
$2M
$2M
$2M
$2M
Amort. of Intangibles
$400.0K
$400.0K
$300.0K
$400.0K
$400.0K
$400.0K
$100.0K
$0
$0
$0
·
·
·
·
·
·
Other Non-cash
·
$-1M
·
·
·
$-7M
·
·
·
$-6M
·
·
·
$-7M
·
·
Operating Cash Flow
$-1M
$-9M
$908.0K
$-785.0K
$-4M
$-17M
$-9M
$-5M
$-5M
$-12M
$2M
$-10M
$-9M
$-15M
$-3M
$-7M
CapEx
$417.0K
$197.0K
$216.0K
$114.0K
$252.0K
$219.0K
$89.0K
$386.0K
$616.0K
$375.0K
$879.0K
$552.0K
$704.0K
$234.0K
$503.0K
$726.0K
Investing Cash Flow
$-417.0K
$-172.0K
$-216.0K
$-114.0K
$-252.0K
$-219.0K
$-2M
$14.0K
$-119.0K
$68.0K
$-563.0K
$66.0K
$-642.0K
$-183.0K
$-503.0K
$9M
Debt Issued
·
·
$0
·
·
·
$9M
·
·
·
$22M
$0
$0
$2M
·
·
Net Debt Issued
·
$-5M
·
·
·
·
·
·
·
·
·
·
·
$1M
·
·
Stock Issued
·
·
·
·
$0
$21M
·
·
·
·
·
·
·
·
·
·
Net Stock Activity
·
·
·
·
·
$21M
·
·
·
·
·
·
·
·
·
·
Financing Cash Flow
$7M
$-6M
$-1M
$18M
$1.0K
$19M
$10M
·
·
·
$22M
$0
$-62.0K
$499.0K
$245.0K
$0
Free Cash Flow
·
$-10M
·
·
·
$-17M
·
·
·
$-12M
·
·
·
$-15M
·
·
Kârlılık6
Metrik
Eğilim
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Gross Margin
·
46.9%
·
45.9%
46.6%
49.2%
·
75.6%
74.0%
75.1%
·
65.8%
72.5%
73.3%
·
78.4%
Operating Margin
·
-26.1%
·
-19.6%
-21.1%
-34.4%
·
-41.7%
-51.7%
-39.4%
·
-49.6%
-41.7%
-63.7%
·
-45.2%
Net Margin
·
-31.3%
·
-24.2%
-26.6%
-39.6%
·
-72.0%
-59.8%
-45.2%
·
-52.5%
-27.8%
-67.7%
·
-46.1%
EBITDA Margin
·
-23.9%
·
-19.6%
-21.1%
-31.6%
·
-41.7%
-51.7%
-36.2%
·
-49.6%
-41.7%
-60.4%
·
-45.2%
ROA
·
-8.1%
·
-8.2%
-8.7%
-10.3%
·
-16.0%
-10.0%
-7.6%
·
-8.8%
-4.4%
-9.0%
·
-5.8%
ROE
·
-44.3%
·
-49.2%
-43.5%
-40.2%
·
-56.4%
-30.3%
-20.7%
·
-18.6%
-8.6%
-16.8%
·
-9.9%
Likidite ve Solventlik5
Metrik
Eğilim
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Current Ratio
·
1.7
·
2.2
2.0
2.4
·
3.2
2.6
5.6
·
4.6
5.2
5.4
·
4.0
Quick Ratio
·
1.0
·
1.6
1.3
1.9
·
2.2
2.0
4.5
·
3.3
3.9
4.3
·
3.4
Debt / Equity
·
4.6
·
2.4
2.0
1.6
·
4.9
3.1
2.1
·
1.0
0.8
0.8
·
0.6
LT Debt / Equity
·
4.6
·
2.4
2.0
1.6
·
4.9
2.4
2.1
·
1.0
0.8
0.8
·
0.4
Interest Coverage
·
-4.0
·
-3.3
-4.1
-5.7
·
-4.5
-4.3
-3.8
·
-7.5
-6.4
-7.9
·
-7.0
Verimlilik3
Metrik
Eğilim
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Asset Turnover
·
0.3
·
0.3
0.3
0.3
·
0.2
0.2
0.2
·
0.2
0.2
0.1
·
0.1
Inventory Turnover
·
4.2
·
4.4
3.7
3.0
·
0.6
0.6
0.5
·
0.7
0.6
0.5
·
0.5
Receivables Turnover
·
1.6
·
2.1
1.8
1.5
·
1.2
1.1
1.3
·
1.3
1.4
1.8
·
1.7
Hisse Başına5
Metrik
Eğilim
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Book Value / Share
·
$0.19
·
$0.40
$0.41
$0.54
·
$0.31
$0.64
$0.92
·
$1.31
$1.58
$1.70
·
$2.33
Revenue / Share
·
$0.50
·
$0.55
$0.58
$0.52
·
$0.61
$0.55
$0.59
·
$0.62
$0.62
$0.55
·
$0.61
Cash Flow / Share
·
$-0.14
·
·
·
$-0.28
·
·
·
$-0.41
·
·
·
$-0.54
·
·
Cash / Share
·
$0.19
·
$0.41
$0.17
$0.31
·
$0.69
$1.42
$1.59
·
$1.24
$1.59
$1.95
·
$2.72
EPS (TTM)
$-0.49
$-0.54
·
$-0.83
$-1.14
$-1.32
·
$-1.21
$-1.10
$-0.94
·
$-1.18
$-1.13
$-1.35
·
$-1.39
Değerleme (TTM)11
Metrik
Eğilim
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Revenue TTM
$151M
$152M
·
$130M
$111M
$89M
·
$73M
$72M
$73M
·
$69M
$68M
$67M
·
$62M
Net Income TTM
$-33M
$-37M
·
$-45M
$-49M
$-49M
·
$-36M
$-32M
$-28M
·
$-33M
$-31M
$-37M
·
$-37M
Market Cap
·
$101M
·
$187M
$231M
$242M
·
$23M
$54M
$143M
·
$39M
$62M
$83M
·
$86M
Enterprise Value
·
$149M
·
$225M
$275M
$277M
·
$48M
$71M
$154M
·
$40M
$53M
$64M
·
$48M
P/E
-2.7
-2.7
·
-3.3
-3.1
-2.8
·
-0.6
-1.6
-5.1
·
-1.1
-1.9
-2.2
·
-2.3
P/S
·
0.7
·
1.4
2.1
2.7
·
0.3
0.8
1.9
·
0.6
0.9
1.2
·
1.4
P/B
·
7.6
·
6.8
8.5
6.8
·
2.5
2.8
5.2
·
1.0
1.4
1.7
·
1.4
P / Tangible Book
·
·
·
·
·
·
·
2.5
2.8
5.2
·
1.0
1.4
1.7
·
1.4
P / Cash Flow
·
-10.7
·
·
·
-14.3
·
·
·
-11.9
·
·
·
-5.4
·
·
EV / Revenue
·
1.0
·
1.7
2.5
3.1
·
0.7
1.0
2.1
·
0.6
0.8
1.0
·
0.8
Earnings Yield
-33.9%
-37.2%
·
-30.4%
-32.7%
-35.9%
·
-159.2%
-61.1%
-19.8%
·
-87.4%
-52.6%
-46.4%
·
-43.7%
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar
Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
16
Metrik
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Gelir
$149M
$75M
$71M
$65M
$55M
Brüt Kâr Marjı %
48.5%
72.3%
72.5%
76.3%
78.9%
Faaliyet Kâr Marjı %
-21.1%
-46.2%
-42.8%
-53.8%
-49.8%
Net Gelir
$-39M
$-44M
$-30M
$-37M
$-31M
Seyreltilmiş Hisse Başı Kâr
$-0.59
$-1.38
$-1.05
$-1.38
$-1.22
Metrik
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Borç / Öz Sermaye
2.9
2.0
1.7
0.6
0.4
Cari Oran
2.0
1.9
4.7
3.0
7.3
Cari Oran
1.5
1.3
3.8
2.5
6.5
Metrik
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Serbest Nakit Akışı
$-21M
$-32M
$-34M
$-34M
$-30M
Kurumsal Sahipler (13F)
99 dosya
· $52.4M toplam
· Tarih itibarıyla 30 Haziran 2026
17
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler99
Tutulan Değer$52.4M
Yeni pozisyonlar17
Çıkan pozisyonlar28
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
Yeni pozisyonlar
Çıkan pozisyonlar
Artırıldı
Azaldı
Net hisse senedi değişimi
17 (-12 önceki Ç'ye göre)
28 (+6 önceki Ç'ye göre)
30 (+5 önceki Ç'ye göre)
25 (0 önceki Ç'ye göre)
-4.3M
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
MADRYN ASSET MANAGEMENT, LP, MADRYN HEALTH PARTNERS II, LP, MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP, MADRYN HEALTH ADVISORS II, LP, MADRYN HEALTH ADVISORS GP II, LLC, MADRYN SELECT OPPORTUNITIES, LP, MADRYN SELECT ADVISORS, LP, MADRYN SELECT ADVISORS GP, LLC
×3 başvurular
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri
29 içeriden öğrenenler
· 9 yöneticiler · 14 yönetim kurulu üyeleri
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği
4 ETF'ler tarafından tutuluyor
20
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.